Aura Biosciences' substantial beat on earnings expectations is likely to positively impact investor sentiment and potentially lead to a short-term increase in stock price, similar to the 10% increase observed after the last quarter's earnings beat. However, the lack of revenue growth could temper some of the enthusiasm.